NTLA
Intellia Therapeutics, IncstockNASDAQ
Market OpenNov 19, 2026 3:32:24 PM EST
9.24USD-5.425%(-0.53)5,090,752
Pre-marketNov 19, 2026 9:29:30 AM EST
9.91USD+1.433%(+0.14)
NTLA News
Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London ·
GlobeNewswire Inc.
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·
GlobeNewswire Inc.
Intellia Q3 Loss Widens to $127.5 Million as Launch Costs Rise ·
Securities.io
Intellia concludes Phase III ATTRv-PN study enrolment ·
Clinical Trials Arena
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·
GlobeNewswire Inc.
